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Keratinocyte Antimicrobials
Patients with atopic dermatitis are at greater risk for skin infections
because they are unable to release more antimicrobial peptides during inflam-
mation. Braff and coworkers found that lamellar bodies, the secretory, lipid-
rich granules in the superficial epidermis, act as storage sites for keratinocyte
cathelicidin. Showing that keratinocytes have the enzymatic machinery necessary to
synthesize, store and activate this antimicrobial peptide confirms that the skin functions
as an independent direct immune barrier. This furthers our understanding of the regulation
of keratinocyte-derived antimicrobial peptides and may have an important role in the
treatment of skin disease. J Invest Dermatol 124:394–400, 2005.
A Stitch in Time
Larger keratinocyte carcinoma (KC) lesions are associated with higher morbidity
than less advanced disease. Eide and coworkers explored the association of
potentially modifiable characteristics, including treatment delay, with KC defect
size after Mohs micrographic surgery (MMS). More than one year’s delay
between initial physician examination and MMS was associated with misdiag-
nosis, failure to initially biopsy, and multiple surgical removals, and was ultimately
associated with a doubling of defect size. Skin cancer information campaigns
and screening programs presume that earlier diagnosis can minimize disease
impact, but this study finds that attention to KC care delivery may be a more
important factor in reducing morbidity. J Invest Dermatol 124:308–314, 2005.
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Akt Activates SSc Fibroblasts
Transforming growth factor (TGF)-b plays a prominent role in the pathogenesis of systemic
sclerosis (SSc), a chronic autoimmune, vascular and fibrotic disease. Fibroblasts from
patients with SSc are relatively resistant to apoptosis and TGF- activates the kinase
Akt, which has powerful anti-apoptotic effects. Therefore, Jun and colleagues examined
whether Akt was activated in skin fibroblasts of SSc patients. They showed that, indeed,
TGF-b signaling through Akt contributes to disease pathogenesis. Further study will need to
distinguish whether additional factors, such as other cytokines, growth factors, or ligands
such as CD40L, could also potentially activate Akt. J Invest Dermatol 124:298–303, 2005.
Vitamins for Sunny Days
DNA damage caused
directly by UV radiation
or indirectly by reactive
oxygen species (singlet
oxygen and free radi-
cals) may lead to muta-
tions and consequently,
to skin cancer. Because
antioxidants have been
suggested as protective
against UV-induced epi-
dermal damage, Plac-
zek and coworkers test-
ed 18 volunteers with 3 months oral intake of vitamins C (2 g/
day) and E (1000 IU/day). Results showed a protective effect
against UVB-induced erythema. Significantly reduced thy-
mine (cyclobutane pyrimidine) dimers in the skin post-
treatment suggest this protocol protected against DNA
damage. It remains to be seen whether antioxidants can
also protect against skin cancer. J Invest Dermatol 124:304–
307, 2005.
ß-Carotene: Versatile Molecule
UVA exposure is thought to
cause skin aging mainly by
singlet oxygen (1O2)-dependent
pathways. -carotene (C) sca-
venges 1O2 and other reactive
oxygen species; reduces sun-
burn; and metabolizes to reti-
noic acid, a molecule involved
in skin maintenance. Wertz and
coworkers analyzed how C
influences the response of ir-
radiated HaCaT keratinocytes,
which are exceptionally sensi-
tive to UVA-induced apoptosis.
Multiple genetic mechanisms
were identified and included
but were not restricted to 1O2-
quenching. These findings help
explain conflicting reports on
the efficacy of C as an anti-
oxidant and have implications
for treating photoaging as well as diseases such as skin
cancer and psoriasis. J Invest Dermatol 124:428–434, 2005.
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